Functional organ preservation for laryngeal cancer. Past, present and future
- 1. Kitasato Univ., School of Medicine, Sagamihara, Kanagawa (Japan)
- 2. Univ. Paris Descartes, Faculty of Medicine, Paris (France)
- 3. Univ. of Texas, MD Anderson Cancer Center, TX (United States)
Description
Management of laryngeal cancer has focused on improving survival while preserving function. Over the past 20 years, the trends have shifted from surgery to chemoradiotherapy and presently we are facing various challenges. It is imperative to re-examine what has happened and what can be done. Review of the literature along with our experience in the management of functional organ preservation for laryngeal cancer. There was an increasing use of chemoradiotherapy with a decreasing use of surgery. Inappropriate patient selection along with inability to properly apply salvage surgeries have been presumed to be responsible for survival deterioration in laryngeal cancer. Reports concerning late adverse events after chemoradiotherapy are also increasing. Reconfirmation of the multidisciplinary team approach is imperative. Transoral laser microsurgery can be used for early laryngeal cancer and, in some experienced institutes, for advanced-stage cancers. Supracricoid laryngectomy demonstrated satisfactory oncologic and functional outcomes, based on our experience. Treatment selection for larynx preservation should not merely be decided by guidelines but considering each patient's individual condition. Head and neck surgeons are encouraged to take reasonable risks in performing salvage larynx preservation surgery when it is the only option to save a functioning larynx. (author)
Additional details
Publishing Information
- Journal Title
- Japanese Journal of Clinical Oncology
- Journal Volume
- 42
- Journal Issue
- 3
- Journal Page Range
- p. 155-160
- ISSN
- 0368-2811
INIS
- Country of Publication
- Japan
- Country of Input or Organization
- Japan
- INIS RN
- 43093690
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- CARCINOMAS; CHEMOTHERAPY; COBALT 60; COMBINED THERAPY; FRACTIONATED IRRADIATION; LARYNGECTOMY; LARYNX; LINEAR ACCELERATORS; PATIENTS; RADIATION DOSES; RADIOTHERAPY
- Descriptors DEC
- ACCELERATORS; BETA DECAY RADIOISOTOPES; BETA-MINUS DECAY RADIOISOTOPES; COBALT ISOTOPES; DISEASES; DOSES; INTERMEDIATE MASS NUCLEI; INTERNAL CONVERSION RADIOISOTOPES; IRRADIATION; ISOMERIC TRANSITION ISOTOPES; ISOTOPES; MEDICINE; MINUTES LIVING RADIOISOTOPES; NEOPLASMS; NUCLEAR MEDICINE; NUCLEI; ODD-ODD NUCLEI; RADIOISOTOPES; RADIOLOGY; RESPIRATORY SYSTEM; SURGERY; THERAPY; YEARS LIVING RADIOISOTOPES